Giannoula Lakka Klement
Has grant
Chief Science Officer
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Giannoula Lakka Klement is the Chief Science Officer at Hessian Labs, Inc. in the United States. Her research focuses on innovative treatment strategies for cancer, particularly in the area of minimal residual disease-guided dosing. Recent work includes significant findings on the successful treatment of chemoresistant anaplastic large cell lymphoma using intermittent Lorlatinib dosing.
Recent Grants
Grant: Close
The role of platelets in tumor growth, wound healing and other angiogenesis disea
Open Date: 2010-09-30
Close Date: 2015-02-28
Grant: Close
The role of platelets in angiogenesis
Open Date: 2002-01-01
Close Date: 2003-12-31
Articles (1)
Year:
2022
Collaborators (1)
Veronika Kanderova
-
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.